William Blair Issues Optimistic Estimate for ZVRA Earnings
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at William Blair boosted their Q1 2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note issued to investors on Wednesday, March 12th. William Blair analyst S. Corwin now anticipates that the company will post earnings of ($0.24) per […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at William Blair boosted their Q1 2025 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note issued to investors on Wednesday, March 12th. William Blair analyst S. Corwin now anticipates that the company will post earnings of ($0.24) per […]
